Many in vitro studies show estrogen regulation of the hypothalamic pro
-opiomelanocortin (POMC) system, including a decrease in hypothalamic
POMC mRNA after estradiol treatment, Because such in vivo experiments
do not allow one to determine whether peripheral, interacting systems
or extra-hypothalamic brain regions are involved in this regulation, w
e sought to establish whether estrogen acts directly in hypothalamus t
o decrease POMC mRNA. Using an in vitro approach, we studied effects o
f estradiol ((E) over dot(2)) on POMC/cyclophilin mRNA concentrations
(RNAse protection assays) in neuronal cultures derived from day 17 fet
al rat hypothalamus. Chemically defined medium was deprived of progest
erone for 2 days prior to E-2 treatment and for the duration of the st
udy. E-2 (10(-13)-10(-9) M) dose-dependently decreased POMC mRNA conce
ntrations during a 2-day treatment. Whereas the lowest dose (10(-13) M
) of E-2 resulted in a statistically significant 44% decrease In POMC
mRNA concentrations relative to control cultures, this inhibitory effe
ct was lost because higher doses (10(-11) and 10(-9) M) did not produc
e statistically significant decrements (22 and 16%, respectively) in P
OMC mRNA concentrations. Additional time course studies revealed that
this decrease in POMC mRNA can be seen as early as 4 h after E-2 (10(-
13) M) treatment. We conclude that E-2 inhibition of POMC mRNA concent
rations in hypothalamic neuronal cultures indicates that this inhibiti
on can occur directly in hypothalamus. (C) 1997 Elsevier Science B.V.